SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-195134
Filing Date
2022-07-15
Accepted
2022-07-15 17:17:38
Documents
6
Effectiveness Date
2022-07-15

Document Format Files

Seq Description Document Type Size
1 S-8 d305464ds8.htm S-8 36876
2 EX-5.1 d305464dex51.htm EX-5.1 5895
3 EX-23.1 d305464dex231.htm EX-23.1 1913
4 EX-99.4 d305464dex994.htm EX-99.4 3835
5 EX-FILING FEES d305464dexfilingfees.htm EX-FILING FEES 14705
6 GRAPHIC g305464dsp3.jpg GRAPHIC 3282
  Complete submission text file 0001193125-22-195134.txt   68847
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266178 | Film No.: 221087600
SIC: 2834 Pharmaceutical Preparations